| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 09/07/2001 | WO2001013901A3 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 09/07/2001 | WO2001010383A3 Caspase inhibitors and uses thereof |
| 09/07/2001 | WO2001005823A3 Tryptase inhibitor |
| 09/07/2001 | WO2000075107A3 Bradykinin receptor antagonists |
| 09/07/2001 | WO2000046389A9 Process for the preparation of pseudomonic acid a antibiotic by microbiological method |
| 09/07/2001 | CA2401869A1 Agent for the treatment of wounds |
| 09/07/2001 | CA2401704A1 Salmon-origin chondroitin sulfate |
| 09/07/2001 | CA2401697A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 09/07/2001 | CA2401667A1 Pde iv inhibiting amides, compositions and pharmaceutical use |
| 09/07/2001 | CA2401660A1 Lipid metabolism enzymes |
| 09/07/2001 | CA2401659A1 Il-8 receptor antagonists |
| 09/07/2001 | CA2401621A1 Modulation of the activity of the endothelial cel surface receptor ecrtp/dep-1 in the regulation of angiogenesis |
| 09/07/2001 | CA2401489A1 Oxygen-containing heterocyclic compounds |
| 09/07/2001 | CA2401357A1 Tissue degradation inhibitor agent |
| 09/07/2001 | CA2401340A1 Compositions and methods for the treatment of inflammatory disease using topoisomerase inhibitors |
| 09/07/2001 | CA2401336A1 Inhibitors of melanocyte tyrosinase as topical skin lighteners |
| 09/07/2001 | CA2400649A1 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors |
| 09/07/2001 | CA2399704A1 Pyrimidine compounds |
| 09/07/2001 | CA2398685A1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 09/07/2001 | CA2374585A1 Antimicrobial sanitizing lotion with skin protection properties |
| 09/06/2001 | US20010020034 Isothiazole derivatives useful as anticancer agents |
| 09/06/2001 | US20010020021 Metalloprotease inhibitor |
| 09/06/2001 | US20010020013 Polymerase inhibitors |
| 09/06/2001 | US20010019711 Mixture containing anionic surfactants and nonionic emulsifiers |
| 09/06/2001 | DE10035735A1 Composition preventing hair loss contains a combination of biotin or caffeine as effective ingredient together with a 10-18C fatty acid or salt |
| 09/05/2001 | EP1130123A2 Diagnostic method |
| 09/05/2001 | EP1129715A1 Use of magnesium, calcium and silicon for the healing of different diseases and to the general well-being |
| 09/05/2001 | EP1129711A2 Pinolenic acid against diabetes |
| 09/05/2001 | EP1129699A1 Topical compositions containing whey protein |
| 09/05/2001 | EP1129697A1 Composition, particularly for cosmetics comprising a pentacyclic triterpene acid |
| 09/05/2001 | EP1129695A1 Cosmetic or dermatological sunscreen formulations |
| 09/05/2001 | EP1129694A1 Use of components for modifying physico-chemical properties of the skin and/or the mucosal tissue as adhesion prevention/decreasing adhesion agents for microorganisms |
| 09/05/2001 | EP1129193A1 Chemokine beta-7 |
| 09/05/2001 | EP1129189A2 Human cell surface receptor proteins |
| 09/05/2001 | EP1129086A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 09/05/2001 | EP1129077A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 09/05/2001 | EP1129075A1 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as vegf receptor tyrosine kinase inhibitors |
| 09/05/2001 | EP1129074A2 Antrhranilic acid amides and the use thereof as medicaments |
| 09/05/2001 | EP1128844A1 Methods for enhancing wound healing |
| 09/05/2001 | EP1128843A2 Vaccine against papillomatous digital dermatitis (pdd) |
| 09/05/2001 | EP1128830A1 Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| 09/05/2001 | EP1128826A1 Chromone enteric release formulation |
| 09/05/2001 | EP1128812A1 Nano-emulsion of 5-aminolevulinic acid |
| 09/05/2001 | EP1128731A1 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof |
| 09/05/2001 | EP0731708B1 Extract from the leaves of ginkgo biloba |
| 09/05/2001 | CN1311822A Gene therapy method |
| 09/05/2001 | CN1311796A Peptide antiangiogenic drugs |
| 09/05/2001 | CN1311775A Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 09/05/2001 | CN1311767A Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 09/05/2001 | CN1311682A Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol |
| 09/05/2001 | CN1311678A Substituted tricyclic pyrazole derivatives with protein kinase activity |
| 09/05/2001 | CN1311676A Compound that inhibit the binding of integrins to their receptors |
| 09/05/2001 | CN1311674A Antioxidant, antiproliferous compositions, comprising a carnitine and a cerotenoid |
| 09/05/2001 | CN1311671A Peptidyl-prolyl i-(cis)-trans isomerase inhitors and uses thereof |
| 09/05/2001 | CN1311629A Inhibitors of transcription factor NF-KB |
| 09/05/2001 | CN1311628A Method and composition for the treatment of epidermal irritations and infections |
| 09/05/2001 | CN1310996A Acne face cleaning cream made of Chinese herb medicine contg. ginseng and seeds of honey dew melon |
| 09/05/2001 | CN1310994A Cosmetics or light prevention prepn. for dermatosis |
| 09/05/2001 | CN1070374C Traditional Chinese medicinal prepn. for treating various kinds of pustule, lump and ulceration |
| 09/05/2001 | CN1070369C Altering hair growth speed and cheracteristics |
| 09/05/2001 | CN1070366C 洗澡剂 Bathing agent |
| 09/05/2001 | CN1070364C Cosmetic or skin-care composition of emulsion of oil covered with water formed with oil drops covered with liquid |
| 09/04/2001 | US6285537 Stress-follower circuit configuration |
| 09/04/2001 | US6284881 A nucleic acid molecule; diagnosis and therpy for allergies, parasitic infections, b cell neoplasia and atopic diseases |
| 09/04/2001 | US6284768 Src family SH2 domain inhibitors |
| 09/04/2001 | US6284749 Mixture of fungicide with chelate compound |
| 09/04/2001 | US6284741 Genetic engineered nucleic acid |
| 09/04/2001 | US6284515 Signal recognition particle polypeptides and polynucleotides |
| 09/04/2001 | US6284258 Long-acting, chemical-resistant skin emollients, moisturizers, and strengtheners |
| 09/04/2001 | US6284257 Cosmetic water emulsion containing at least one vegetable oil |
| 09/04/2001 | US6284233 Antiwrinkle composition comprising a combination of tightening polymers of synthetic and/or natural origin and of dendritic polyesters |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062937A1 Skin infection-related retroviral sequences |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062758A1 Pteridine compounds for the treatment of psoriasis |
| 08/30/2001 | WO2001062757A1 Novel compounds |
| 08/30/2001 | WO2001062756A1 Pyridinylimidazoles |
| 08/30/2001 | WO2001062750A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 08/30/2001 | WO2001062742A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 08/30/2001 | WO2001062733A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors |
| 08/30/2001 | WO2001062729A1 Novel compounds |
| 08/30/2001 | WO2001062728A1 Novel compounds |
| 08/30/2001 | WO2001062725A2 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | WO2001062721A1 Novel use of phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062714A1 Novel phenylheteroalkylamine derivatives |
| 08/30/2001 | WO2001062706A1 Aminoadamantane derivatives as therapeutic agents |
| 08/30/2001 | WO2001062312A1 Foam-forming wound dressing |
| 08/30/2001 | WO2001062294A1 Preventive or therapeutic drugs for dermatitises containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062293A1 Preventive or therapeutic drugs for various eosinophilia-related diseases containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062292A1 Preventive or therapeutic drugs for fibrosis containing chymase inhibitors as the active ingredient |
| 08/30/2001 | WO2001062278A1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 08/30/2001 | WO2001062276A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 08/30/2001 | WO2001062262A1 Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 08/30/2001 | WO2001062252A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062251A1 Tyrosine kinase inhibitors |
| 08/30/2001 | WO2001062250A1 Thiazolium compounds and treatments of disorders associated with protein aging |
| 08/30/2001 | WO2001062237A2 Compositions for the treatment of alopecia and other disorders of the pilosebaceous apparatus |